Featured Research

from universities, journals, and other organizations

Physicians Study Whether "Super-Aspirin" Prevents Alzheimer's

Date:
November 20, 1998
Source:
University Of Rochester
Summary:
Doctors at the University of Rochester and 39 other medical centers around the nation have begun a research study to see if a drug known as a super-aspirin -- an investigational compound made possible by basic medical research during the last decade at the University's Medical Center -- helps prevent Alzheimer's disease.

Doctors at the University of Rochester and 39 other medical centers around the nation have begun a research study to see if a drug known as a super-aspirin -- an investigational compound made possible by basic medical research during the last decade at the University's Medical Center -- helps prevent Alzheimer's disease.

Twenty Rochester-area patients will be part of a group of about 1,300 people nationwide who will be treated with the experimental drug, which is similar to ibuprofen, naproxen, aspirin, and other painkillers, but appears to be safer and much more efficient at squelching pain and inflammation. The first of the drugs is currently being reviewed for the treatment of arthritis and may be available next year.

The drugs target cycloxygenase-2 or cox-2, an enzyme in the body first discovered and cloned by a University team led by Don Young and Kerry O'Banion. Scientists believe the enzyme is at the root of the pain and inflammation we feel from a variety of ailments, including arthritis. Existing painkillers like ibuprofen and aspirin inhibit both cox-2 and cox-1, a closely related enzyme. For years physicians believed that knocking out cox-1 helped patients feel better, but now most doctors believe that cox-2 is the real pain-causing culprit in many illnesses. Currently drugs targeting cox-2 are being tested as a way to treat arthritis more aggressively with fewer side effects, and they're being looked at as a possible way to prevent colon cancer.

This study is one of the first to see whether such drugs might prevent or delay Alzheimer's disease. During the past few years, O'Banion and others have discovered that cox-2 is active in the brains of people who have the disease. Though the precise cause of Alzheimer's disease is still a mystery, scientists believe the enzyme plays some role in the sickness and death of brain cells of patients. Since cox-2 inhibitors muck up the enzyme's activity, they might help protect the brain against injury.

"This is a very exciting step in our efforts against Alzheimer's disease," says Pierre Tariot, a leader of the study and director of the University's Program in Neurobehavioral Therapeutics at Monroe Community Hospital, the University's main Alzheimer's treatment site. "Until now our efforts have been directed toward treating the symptoms of the disease, and as a result we have a whole series of drugs available or in development for people who have full-blown Alzheimer's."

In the study, Tariot and Anton Porsteinsson, the other principal investigator at the University, will randomly assign patients to receive either the cox-2 inhibitor Vioxx or a placebo for two years, and patients will be evaluated every few months by physicians. (Vioxx is manufactured by Merck, which is funding the $6 million nationwide study.) If the drug does work, fewer patients will develop the disease than physicians would normally expect.

"This is one of the first studies to look at possibly delaying the onset of Alzheimer's disease in people who don't have it yet but are at risk," adds Tariot. "It's remarkable that we can even consider the possibility of prevention; just 10 years ago that thought was preposterous."


Story Source:

The above story is based on materials provided by University Of Rochester. Note: Materials may be edited for content and length.


Cite This Page:

University Of Rochester. "Physicians Study Whether "Super-Aspirin" Prevents Alzheimer's." ScienceDaily. ScienceDaily, 20 November 1998. <www.sciencedaily.com/releases/1998/11/981120075812.htm>.
University Of Rochester. (1998, November 20). Physicians Study Whether "Super-Aspirin" Prevents Alzheimer's. ScienceDaily. Retrieved July 25, 2014 from www.sciencedaily.com/releases/1998/11/981120075812.htm
University Of Rochester. "Physicians Study Whether "Super-Aspirin" Prevents Alzheimer's." ScienceDaily. www.sciencedaily.com/releases/1998/11/981120075812.htm (accessed July 25, 2014).

Share This




More Health & Medicine News

Friday, July 25, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

Beatings and Addiction: Pakistan Drug 'clinic' Tortures Patients

AFP (July 24, 2014) A so-called drugs rehab 'clinic' is closed down in Pakistan after police find scores of ‘patients’ chained up alleging serial abuse. Duration 03:05 Video provided by AFP
Powered by NewsLook.com
Too Few Teens Receiving HPV Vaccination, CDC Says

Too Few Teens Receiving HPV Vaccination, CDC Says

Newsy (July 24, 2014) The Centers for Disease Control and Prevention is blaming doctors for the low number of children being vaccinated for HPV. Video provided by Newsy
Powered by NewsLook.com
New Painkiller Designed To Discourage Abuse: Will It Work?

New Painkiller Designed To Discourage Abuse: Will It Work?

Newsy (July 24, 2014) The FDA approved Targiniq ER on Wednesday, a painkiller designed to keep users from abusing it. Like any new medication, however, it has doubters. Video provided by Newsy
Powered by NewsLook.com
Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Doctor At Forefront Of Fighting Ebola Outbreak Gets Ebola

Newsy (July 24, 2014) Sheik Umar Khan has treated many of the people infected in the Ebola outbreak, and now he's become one of them. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

    Health News

      Environment News

        Technology News



          Save/Print:
          Share:

          Free Subscriptions


          Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

          Get Social & Mobile


          Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

          Have Feedback?


          Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
          Mobile: iPhone Android Web
          Follow: Facebook Twitter Google+
          Subscribe: RSS Feeds Email Newsletters
          Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins